Effective Recovery of a PICC Line in a Catheter-Related Bloodstream Infection Due to Multidrug-Resistant Ralstonia mannitolilytica with Topical Minocycline: A Case Study - Report - MDSpire

Effective Recovery of a PICC Line in a Catheter-Related Bloodstream Infection Due to Multidrug-Resistant Ralstonia mannitolilytica with Topical Minocycline: A Case Study

  • By

  • Mu-Yun Gong

  • Pan-Pan Sun

  • Zheng-Ning Chen

  • Jia-Ai Li

  • February 16, 2026

  • 0 min

Share

Effective Recovery of a PICC Line in a Catheter-Related Bloodstream Infection

Overview

This case study details the successful management of a PICC-related bloodstream infection caused by multidrug-resistant Ralstonia mannitolilytica in a 47-year-old female patient. The infection was effectively controlled using topical minocycline ointment, allowing for catheter retention despite the patient's critical condition.

Background

Incorporate statistics on mortality rates and resistance patterns for Ralstonia mannitolilytica.

Data Highlights

No numerical data or trial data available in the article.

Key Findings

  • The patient was diagnosed with CRBSI caused by multidrug-resistant Ralstonia mannitolilytica.
  • Initial treatment with systemic antibiotics and topical antiseptics did not improve local symptoms.
  • Topical minocycline ointment was used successfully to control the infection.
  • The catheter was retained through a multidisciplinary approach and standardized catheter care.
  • This case suggests that topical antimicrobial therapy may be a viable option for managing CRBSI in patients with limited vascular access.

Clinical Implications

Clinicians should consider the use of topical antimicrobial agents like minocycline in cases of CRBSI where catheter removal is not feasible. This approach may provide an alternative treatment strategy for managing infections caused by multidrug-resistant organisms.

Conclusion

This case underscores the importance of exploring alternative treatment modalities for CRBSI, particularly in patients with complex medical conditions and limited options for vascular access.

References

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. CDC, Infection Control, 2024 -- Intravascular Catheter-related Infection (BSI) Prevention Guidelines
  6. Citius Pharmaceuticals, PR Newswire, 2024 -- Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
  7. PMC, 2023 -- A urokinase-associated outbreak of Ralstonia mannitolilytica bloodstream infections in haemodialysis patients in north-eastern Italy, January to April 2023
  8. Intravascular Catheter-related Infection (BSI) Prevention Guidelines | Infection Control | CDC
  9. Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
  10. A urokinase-associated outbreak of Ralstonia mannitolilytica bloodstream infections in haemodialysis patients in north-eastern Italy, January to April 2023 - PMC

Original Source(s)

Related Content